Medulloblastomas overexpress the p53-inactivating oncogene WIP1/PPM1D

Robert C. Castellino , Massimiliano De Bortoli , Xiongbin Lu , Sung-Hwan Moon
Journal of Neuro-Oncology 86 ( 3) 245 -256

155
2008
Lack of elevated liver carcinogenicity of aminophenylnorharman in p53-deficient mice

Takeshi Iidaka , Tetsuya Tsukamoto , Yukari Totsuka , Akihiro Hirata
Cancer Letters 217 ( 2) 149 -159

6
2005
Organ-specific susceptibility of p53 knockout mice to N-bis(2-hydroxypropyl)nitrosamine carcinogenesis

Akihiro Hirata , Tetsuya Tsukamoto , Masami Yamamoto , Hiroki Sakai
Cancer Letters 238 ( 2) 271 -283

4
2006
p53: guardian AND suppressor of longevity?

Lawrence A. Donehower
Experimental Gerontology 40 ( 1) 7 -9

43
2005
Cross‐species identification of a plasma microRNA signature for detection, therapeutic monitoring, and prognosis in osteosarcoma

Wendy Allen‐Rhoades , Lyazat Kurenbekova , Laura Satterfield , Neha Parikh
Cancer Medicine 4 ( 7) 977 -988

68
2015
Aging-associated truncated form of p53 interacts with wild-type p53 and alters p53 stability, localization, and activity

Lynette Moore , Xiongbin Lu , Nader Ghebranious , Stuart Tyner
Mechanisms of Ageing and Development 128 ( 11-12) 717 -730

25
2007
How does suppression of IGF-1 signaling by DNA damage affect aging and longevity?

George Hinkal , Lawrence A. Donehower
Mechanisms of Ageing and Development 129 ( 5) 243 -253

28
2008
Augmented cancer resistance and DNA damage response phenotypes in PPM1D null mice.

Bonnie Nannenga , Xiongbin Lu , Melissa Dumble , Marc Van Maanen
Molecular Carcinogenesis 45 ( 8) 594 -604

77
2006
Visual genotyping of a coat color tagged p53 mutant mouse line.

Binhai Zheng , Hannes Vogel , Lawrence A. Donehower , Allan Bradley
Cancer Biology & Therapy 1 ( 4) 433 -435

18
2002
Infrequent p53 mutations in 7,12‐dimethylbenz[a]anthracene–induced mammary tumors in BALB/c and p53 hemizygous mice

D. Joseph Jerry , Janet S. Butel , Lawrence A. Donehower , Emily J. Paulson
Molecular Carcinogenesis 9 ( 3) 175 -183

52
1994
Effects of genetic background on tumorigenesis in p53-deficient mice

Lawrence A Donehower , Michele Harvey , Hannes Vogel , Mark J McArthur
Molecular Carcinogenesis 14 ( 1) 16 -22

234
1995
Integrated Analysis of TP53 Gene and Pathway Alterations in The Cancer Genome Atlas

Lawrence A. Donehower , Thierry Soussi , Anil Korkut , Yuexin Liu
Cell Reports 28 ( 5) 3010

343
2019
Complementation of human immunodeficiency virus type 1 vif mutants in some CD4+ T-cell lines

Michael Hevey , Lawrence A. Donehower
Virus Research 33 ( 3) 269 -280

10
1994
Activation of WIP1 phosphatase by HTLV-1 Tax mitigates the cellular response to DNA damage.

Tajhal Dayaram , Francene J. Lemoine , Lawrence A. Donehower , Susan J. Marriott
PLOS ONE 8 ( 2)

14
2013
Mice deficient for p53 are developmentally normal but susceptible to spontaneous tumours

Lawrence A. Donehower , Michele Harvey , Betty L. Slagle , Mark J. McArthur
Nature 356 ( 6366) 215 -221

5,994
1992
Dephosphorylation of γH2AX by WIP1: An important homeostatic regulatory event in DNA repair and cell cycle control

Sung-Hwan Moon , Thuy-Ai Nguyen , Yolanda Darlington , Xiongbin Lu
Cell Cycle 9 ( 11) 2092 -2096

51
2010
The type 2C phosphatase Wip1: An oncogenic regulator of tumor suppressor and DNA damage response pathways

Xiongbin Lu , Thuy-Ai Nguyen , Sung-Hwan Moon , Yolanda Darlington
Cancer and Metastasis Reviews 27 ( 2) 123 -135

187
2008
Activities of wildtype and mutant p53 in suppression of homologous recombination as measured by a retroviral vector system.

Xiongbin Lu , Guillermina Lozano , Lawrence A. Donehower
Mutation Research 522 ( 1) 69 -83

30
2003
Murine tumor suppressor models.

Sundaresan Venkatachalam , Lawrence A. Donehower
Mutation Research 400 ( 1) 391 -407

20
1998
Rescue of embryonic lethality in Mdm2-deficient mice by absence of p53

Stephen N. Jones , Amy E. Roe , Lawrence A. Donehower , Allan Bradley
Nature 378 ( 6553) 206 -208

1,089
1995